← Back to all articles
PharmacologyPubMed Verified

Pharmacokinetics of hoasca alkaloids in healthy humans

Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, Andrade EN, Andrade EO, Mash DC

Journal of Ethnopharmacology (1999)

Pharmacokinetic study
Abstract

First detailed pharmacokinetic study of ayahuasca alkaloids (DMT, harmine, harmaline, THH) in 15 experienced users. Established plasma concentration curves, half-lives, and bioavailability.

Participants15
Citations420
Study TypePharmacokinetic study
pharmacokineticsalkaloidsDMTharminebioavailability
DOI: 10.1016/S0378-8741(98)00168-8View on PubMed

Related Articles

Pharmacology

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans

Wittayakarn N, Tan YM et al.

Toxicological Sciences, 2025
Pharmacology

Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial

Mueller MJ, Aicher HD et al.

International Journal of Neuropsychopharmacology, 2024
Pharmacology

Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells

Salles G, de Carvalho Alves I et al.

Archives of Toxicology, 2025
Pharmacology

Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects

Aicher HD, Mueller MJ et al.

Frontiers in Psychiatry, 2024